Futures on Wall Street are currently pointing to a negative start to Tuesday's trading session, even as investors brushed aside concerns arising from the Moody's downgrade. Monday's session saw the resultant gap-down from the downgrade being swiftly bought into,

US stocks managed to eke out gains on Monday as bond yields eased off bigger gains and Wall Street largely shrugged off Moody's downgrade of the US credit rating. Meanwhile, investors digested developments in President Trump's tariff salvos.

U.S. stocks have mounted a strong comeback, but lurking behind the optimism is one of the market’s old, expensive problems: stocks are pricey once again.

UnitedHealth volatility highlights a key difference between the Dow and the S&P 500. UnitedHealth’s sharp decline and subsequent rebound had an outsized impact on the Dow, while the S&P 500 remained relatively unaffected, underscoring how index structure drives performance sensitivity.

UnitedHealth has gone from bad to worse, and its drop is impacting the Dow Jones Industrial Average even more than it is the S&P 500.

Soft inflation data lifted major U.S. stock indexes Tuesday, except for one notable exception: the Dow Jones Industrial Average, the blue-chip index that for many is synonymous with “the stock market.

The Dow Jones Industrial Average reversed its earlier losses Monday afternoon, as investors continued to digest the potential impact of Moody's downgrade of the U.S. sovereign rating from triple-A. The Dow was down 317 points to as low as 42,

Investors eye more trade deals, updates from President Trump’s trip to the Middle East and fresh consumer inflation data after U.S. stocks soared Monday as investors celebrated major progress on U.S.-China trade talks.

Dow Jones outperforms with help from health stocks; S&P500 and Nasdaq rally while Nvidia earnings loom next week.

Stock futures fell and Treasury yields soared on Monday as investors responded to news that a major ratings agency had downgraded its assessment of U.S. federal government debt.